Chief executive

Albert Bourla

Chairman & CEO · Pfizer Inc

1 disclosed trade · 12 Aug 2026 to 12 Aug 2026 · latest filed 12 Aug 2026

Chief executive of Pfizer Inc (PFE), tracked from the executive's own SEC Form 4 disclosures.

Net buying by company

Estimated net buying by company: disclosed buys minus sells, trades from 12 Aug 2026 to 12 Aug 2026. Source: SEC Form 4 filings, filed to 12 Aug 2026.
CompanyShare of net buyingEst. net
Common Stock (PFE)100.0%$1.0M

Recent disclosed trades

1 most recent of 1 trades. Amounts are shares times the reported price. Source: SEC Form 4 filings, filed to 12 Aug 2026.
CompanyTrade dateActionAmountFiled
Common Stock (PFE)2026-08-12Buy$1,000,9202026-08-12

Source: SEC Form 4 filings, trades from 12 Aug 2026 to 12 Aug 2026, latest filed 12 Aug 2026. Executives report their own trades on Form 4 within two business days.

Open the interactive profile: all trades, compare with others